Cargando…

The Prevalence of Inflammatory Bowel Disease (IBD) in Patients with Multiple Sclerosis (MS): A Systematic Review and Meta-Analysis

BACKGROUND: This systematic review and meta-analysis aim to update the pooled prevalence of Inflammatory bowel disease (IBD) in patients with multiple sclerosis (MS). METHODS: Two researchers independently and systematically searched PubMed, Scopus, EMBASE, Web of Science, and google scholar. They a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nasirzadeh, Amirreza, Jahanshahi, Reza, Ghajarzadeh, Mahsa, Mohammadi, Aida, Moghadasi, Abdorreza Naser
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580199/ https://www.ncbi.nlm.nih.gov/pubmed/37854988 http://dx.doi.org/10.4103/ijpvm.ijpvm_44_22

Ejemplares similares

Emotional Intelligence (EI) of Patients with Multiple Sclerosis (MS)
por: GHAJARZADEH, Mahsa, et al.
Publicado: (2014)

The prevalence of COVID-19 infection in patients with multiple sclerosis (MS): A systematic review and meta-analysis
por: Ghajarzadeh, Mahsa, et al.
Publicado: (2021)

The prevalence of COVID-19 infection in patients with multiple sclerosis (MS): a systematic review and meta-analysis
por: Moghadasi, Abdorreza Naser, et al.
Publicado: (2021)

Knowledge regarding COVID-19 pandemic in patients with multiple sclerosis (MS): A report from Iran
por: Sahraian, Mohammad Ali, et al.
Publicado: (2020)

The relationship between retinal layer thickness and cognition in patients with multiple sclerosis: A systematic review of current literature
por: Moghadasi, Abdorreza Naser, et al.
Publicado: (2023)

Prevalence of COVID-19 infection in patients with neuromyelitis optica spectrum disorder (NMOSD): A systematic review and meta-analysis
por: Ghajarzadeh, Mahsa, et al.
Publicado: (2021)

Alternate dosing of fingolimod in relapsing-remitting multiple sclerosis: A systematic review
por: Ghadiri, Fereshteh, et al.
Publicado: (2023)

Validity and Reliability of the Persian Version of the PERception de la Scle’rose En Plaques et de ses Pousse’es Questionnaire Evaluating Multiple Sclerosis-related Quality of Life
por: Ghajarzadeh, Mahsa, et al.
Publicado: (2016)

Is Celiac Disease (CD) Prevalent in Patients with Multiple Sclerosis (MS): A Systematic Review and Meta-Analysis
por: Olfati, Hamide, et al.
Publicado: (2022)

Can multiple sclerosis as a cognitive disorder influence patients’ dreams?
por: Moghadasi, Abdorreza Naser, et al.
Publicado: (2013)

Neuroplasticity in Early Onset Multiple Sclerosis
por: Naser Moghadasi, Abdorreza
Publicado: (2014)

The study of COVID-19 infection following vaccination in patients with multiple sclerosis
por: Ghadiri, Fereshteh, et al.
Publicado: (2022)

Association of Limb-Girdle muscular dystrophy with multiple sclerosis: A case report
por: Arzani, Mahsa, et al.
Publicado: (2018)

The perspective of Iranian patients with multiple sclerosis on the third dose of COVID-19 vaccine
por: Ghadiri, Fereshteh, et al.
Publicado: (2022)

Evaluating the relationship between emotional intelligence and cognitive disorders in patients with Multiple Sclerosis
por: Owji, Mahsa, et al.
Publicado: (2018)

Multiple Sclerosis in Parsis: A Historical Issue
por: NASER MOGHADASI, Abdorreza
Publicado: (2014)

Is anemia a probable cause of fatigue in patients with multiple sclerosis?
por: Mir-Reza, Soha, et al.
Publicado: (2013)

Evaluation of the Opinion of Patients With Multiple Sclerosis on the Outcomes of Catching COVID-19 and Its Effects on the MS Symptoms
por: Rezaeimanesh, Nasim, et al.
Publicado: (2020)

Bladder Dysfunction in Iranian Patients with Multiple Sclerosis
por: Azadvari, Mohaddeseh, et al.
Publicado: (2020)

Encephalopathy associated with COVID-19 in a patient with multiple sclerosis
por: Naser Moghadasi, Abdorreza
Publicado: (2020)

Adverse events reported by Iranian patients with multiple sclerosis after the first dose of Sinopharm BBIBP-CorV
por: Ali Sahraian, Mohammad, et al.
Publicado: (2021)

A 31-year-old female patient with concurrent clinical onset of multiple sclerosis and COVID-19: Possible role of SARS-CoV-2 in the pathogenesis of multiple sclerosis
por: Naser Moghadasi, Abdorreza
Publicado: (2021)

Fear of re-infection, relapse, and anxiety during COVID-19 pandemic in patients with multiple sclerosis: A multi-center study
por: Moghadasi, Abdorreza Naser, et al.
Publicado: (2023)

The big challenge for neurologists in treating patients with multiple sclerosis in the post-COVID-19 era
por: Naser Moghadasi, Abdorreza
Publicado: (2020)

Lack of Attention to the Administration of Fampridine as a Symptomatic Drug in Iranian Multiple Sclerosis Patients
por: Moghadasi, Abdorreza Naser
Publicado: (2021)

Evaluation of the rate of COVID-19 infection, hospitalization and death among Iranian patients with multiple sclerosis
por: Sahraian, Mohammad Ali, et al.
Publicado: (2020)

Prevalence of Seizure/Epilepsy in Patients with Multiple Sclerosis: A Systematic Review and Meta-Analysis
por: Mirmosayyeb, Omid, et al.
Publicado: (2021)

Is Body Mass Index (BMI) Associated with Risk and Outcomes of COVID-19 in Iranian Multiple Sclerosis Patients?
por: Rezaeimanesh, Nasim, et al.
Publicado: (2023)

Age at menarche and risk of multiple sclerosis (MS): a systematic review and meta-analysis
por: Azimi, Amirreza, et al.
Publicado: (2019)

Characteristics and management of multiple sclerosis patients during the Omicron era: is there a concern about the MS course in the face of the new variant of COVID-19?
por: Paybast, Sepideh, et al.
Publicado: (2022)

Psychometric properties of the Persian version of emotions and attitudes towards MRI” (MRI-EMA)
por: Naser Moghadasi, Abdorreza, et al.
Publicado: (2023)

Relationship between Sleep Quality and Quality of Life in Patients with Multiple Sclerosis
por: Sarraf, Payam, et al.
Publicado: (2014)

Are patients with multiple sclerosis (MS) at higher risk of COVID-19 infection?
por: Ghajarzadeh, Mahsa, et al.
Publicado: (2020)

Thrombotic microangiopathy associated with interferon-beta treatment in patients with multiple sclerosis
por: Baghbanian, Seyed Mohammad, et al.
Publicado: (2018)

Importance of T-cell response to COVID-19 vaccination in patients with multiple sclerosis treated by anti-CD20 therapies: New vaccines are required to be developed
por: Naser Moghadasi, Abdorreza
Publicado: (2021)

Validation of the Persian version of dysphagia in multiple sclerosis questionnaire for the assessment of dysphagia in multiple sclerosis
por: Jafari, Zahra, et al.
Publicado: (2018)

Prevalence of Multiple Sclerosis (MS) in Zanjan Province of Iran
por: Ghajarzadeh, Mahsa, et al.
Publicado: (2020)

The effect of body mass index on the morbidity and outcomes of COVID-19 in Iranian patients with multiple sclerosis
por: Rezaeimanesh, Nasim, et al.
Publicado: (2023)

Bacterial meningitis in a patient with multiple sclerosis receiving Tysabri
por: Moghadasi, Abdorreza Naser, et al.
Publicado: (2016)

A Smartphone-based Application for Self-Management in Multiple Sclerosis
por: Mokhberdezfuli, Mahdieh, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lto9ukfnhvhbg8nkb0tn2bjlr4